Renal & Urinary Disorders — Core Concepts
- Rois Narvaez
- Oct 6, 2025
- 6 min read
The renal system is the body’s filtration and balance hub — removing wastes, regulating electrolytes, controlling blood pressure, and sustaining homeostasis.Advanced renal nursing goes beyond identifying abnormal labs; it requires pattern recognition, hemodynamic awareness, and preventive action before crisis.
Safety Anchors:
🩸 Always correlate urine output trends with hemodynamics — perfusion, not just numbers.
⚠️ Monitor nephrotoxic exposures (contrast dyes, aminoglycosides, NSAIDs).
💊 Renal dosing is safety dosing — check creatinine clearance before administering meds.
⚙️ Assess access patency (thrill/bruit) every shift; no IV, BP, or venipuncture in that limb.
🧫 Invasive urinary procedures = infection control priority.
🧠 Every lab has a story — interpret trajectory, not snapshots.
Clinical Judgment Chain:Identify ↓GFR → locate cause (prerenal/intrarenal/postrenal) → manage early → evaluate compensation → prep escalation (dialysis, transplant, or palliative).
⚗️ 1) Renal Laboratory & Diagnostic Interpretation Table
Test | Normal Range | Purpose / Significance | Advanced Clinical Interpretation | Nursing Implications |
Serum Creatinine (Cr) | 0.6–1.2 mg/dL | Reflects filtration function of kidneys | ↑ = renal impairment; slow rise = CKD, rapid rise = AKI | Monitor trend, adjust medication dosing |
Blood Urea Nitrogen (BUN) | 8–20 mg/dL | End-product of protein metabolism | ↑ with dehydration, GI bleed, or renal failure | Check BUN:Cr ratio to identify prerenal vs renal cause |
BUN:Cr Ratio | 10–20:1 | Evaluates relationship between filtration & reabsorption | >20:1 = prerenal (volume loss), 10–15:1 = intrinsic renal | Guides fluid management and diagnostic focus |
GFR (Glomerular Filtration Rate) | ≥90 normal; <60 = CKD; <15 = ESRD | Estimates filtration capacity | ↓ = nephron loss; used for staging CKD | Stage disease, plan for dialysis or transplant |
Creatinine Clearance (CrCl) | 80–125 mL/min | Timed urine test mirroring GFR | ↓ = impaired filtration | Ensure accurate 24-hr urine collection |
Urinalysis (UA) | — | Screens for infection, protein, glucose, ketones, RBC/WBC | Protein → glomerular damage; WBCs/nitrites → UTI | Collect midstream clean-catch sample |
Urine Specific Gravity | 1.010–1.030 | Measures urine concentration ability | ↑ (>1.030) = dehydration or SIADH; ↓ (<1.010) = renal failure, DI, overhydration | Evaluate hydration, renal concentration ability; trend with osmolality |
Urine Osmolality | 300–900 mOsm/kg | Measures solute concentration (precise vs specific gravity) | ↓ = tubular damage, DI; ↑ = volume depletion, SIADH | Compare serum vs urine osmolality to assess ADH function |
Urine Sodium (Na⁺) | 20–40 mEq/L | Reflects renal tubular sodium handling | <10 mEq/L = prerenal (conservation); >40 = intrinsic renal loss | Helps classify AKI type |
Fractional Excretion of Sodium (FENa) | 1–2% normal | Differentiates prerenal (<1%) vs ATN (>2%) | <1% = intact tubules, volume depletion; >2% = tubular injury | Requires simultaneous urine & plasma Na/Cr levels |
Urine pH | 4.5–8.0 | Indicates acid–base status | Alkaline = infection; acidic = metabolic acidosis | Monitor changes in infection or acid–base disorders |
Proteinuria (Dipstick or 24-hr) | <150 mg/day | Detects glomerular damage | >3.5 g/day = nephrotic syndrome | Monitor for edema, albumin, nutrition |
Microscopic Exam | — | Detects casts, cells, crystals | RBC casts = GN; WBC casts = pyelonephritis | Interpret with UA and clinical findings |
Imaging (US, CT, IVP, MRI) | — | Assesses anatomy, obstruction, stones | IVP contraindicated in renal failure due to contrast nephropathy | Hydrate pre/post-contrast; monitor Cr |
Renal Biopsy | — | Evaluates glomerular disease or rejection | Risk of bleeding; definitive diagnostic tool | Post: flat 4–6 hr, monitor flank pain & hematuria |
🧠 Quick Clinical Pairing Tips:
Specific gravity low + low osmolality = renal tubular damage or overhydration
High specific gravity + high osmolality = dehydration, SIADH, or prerenal AKI
Normal specific gravity (1.010) that doesn’t change = “isosthenuria” → renal failure (kidneys can’t concentrate or dilute urine)
Compare serum and urine osmolality:
Serum high / urine low → DI
Serum low / urine high → SIADH
🧩 2) Major Renal & Urinary Disorders
Disorder | Pathophysiology & Description | Causes / Risk Factors | Diagnostics / Labs | Management / Nursing Interventions |
Acute Kidney Injury (AKI) | Rapid decline in filtration (hours–days); reversible if cause removed. Classified as prerenal, intrarenal, postrenal. | Volume depletion, hypotension, nephrotoxins, obstruction | ↑BUN/Cr, ↓UO, ↑K⁺, metabolic acidosis | Maintain perfusion, fluid challenge if prerenal, remove nephrotoxins, manage electrolytes, prepare for dialysis if refractory |
Chronic Kidney Disease (CKD) | Progressive nephron loss → uremia, fluid overload, metabolic acidosis | DM, HTN, glomerular disease, chronic obstruction | GFR <60 for ≥3 mo, ↑Cr/BUN, anemia, hyperphosphatemia, hypocalcemia | Control HTN (ACE/ARB), restrict Na/K/Phos, erythropoietin therapy, phosphate binders, dialysis education |
Glomerulonephritis (GN) | Immune-mediated glomerular inflammation → ↓filtration, protein loss | Post-strep infection, lupus, HTN, DM | UA: RBC casts, proteinuria, ↑ASO titer, ↑Cr | Antibiotics (if infection), corticosteroids, Na/fluid restriction, monitor BP & renal function |
Nephrotic Syndrome | Glomerular damage → ↑permeability to proteins | Diabetes, lupus, GN | Massive proteinuria >3.5 g/day, hypoalbuminemia, edema, hyperlipidemia | Corticosteroids, ACE inhibitors, diuretics, ↑protein/mod Na diet, infection prevention |
Pyelonephritis | Ascending bacterial infection of renal pelvis & parenchyma | E. coli, obstruction, reflux | UA: WBC casts, ↑WBCs, fever, flank pain | IV antibiotics (broad→narrow), hydration, analgesics, antipyretics, rest |
UTI / Cystitis | Lower tract infection | Short urethra (females), catheters, retention | UA: WBCs, nitrites, cloudy urine | PO antibiotics, fluids 2–3 L/day, hygiene, avoid bladder irritants |
Renal Calculi (Stones) | Mineral salt crystallization in renal pelvis or ureter | Dehydration, high protein, purine, or calcium diet | CT/KUB, UA (hematuria), pain | Pain control, strain urine, fluids 2–3 L/day, lithotripsy or surgical removal |
Hydronephrosis / Obstruction | Urine flow obstruction → kidney dilation | Stones, tumor, BPH | US/CT, ↑Cr | Relieve obstruction (stent/nephrostomy), monitor output |
Polycystic Kidney Disease (PKD) | Genetic cyst formation → nephron compression | Family history (autosomal dominant) | Enlarged kidneys, HTN, hematuria | Manage BP, prevent infection, avoid trauma, prep for transplant |
Renal Cell Carcinoma | Malignancy of renal cortex | Smoking, obesity, chemical exposure | CT, biopsy, hematuria | Nephrectomy, chemo (targeted), monitor for metastasis |
Bladder Cancer | Malignant urothelial tumor | Smoking, chronic irritation, dye exposure | Cystoscopy, hematuria | TURBT, intravesical chemo, urinary diversion teaching |
💊 3) Pharmacologic & Medical Management
Drug Class / Therapy | Example | Purpose | Nursing Implications |
Diuretics | Furosemide, Torsemide | Remove excess fluid | Monitor K⁺/Na⁺, avoid in severe CKD unless ordered |
ACE Inhibitors / ARBs | Lisinopril, Losartan | Control HTN, slow CKD progression | Monitor K⁺, avoid in severe renal failure |
Erythropoietin Stimulating Agents (ESA) | Epoetin alfa | Treat anemia of CKD | Monitor Hgb (target 10–11), assess BP |
Phosphate Binders | Calcium acetate, Sevelamer | Prevent hyperphosphatemia | Give with meals, monitor Ca/Phos balance |
Vitamin D analogs | Calcitriol | Manage hypocalcemia, bone health | Monitor Ca levels, avoid hypercalcemia |
Potassium Binders | Sodium polystyrene sulfonate, Lokelma | Lower serum K⁺ | Monitor stools, Na retention, avoid constipation |
Sodium Bicarbonate | — | Correct metabolic acidosis | Monitor pH, Na load |
Antibiotics | Ciprofloxacin, Cephalosporins | Treat infection | Renal dose adjust; monitor CrCl |
Dialysis Anticoagulation | Heparin | Prevent circuit clotting | Monitor for bleeding, reversal with protamine |
⚙️ 4) Dialysis Therapies (Advanced Clinical)
Type | Mechanism / Access | Indications | Key Nursing Management | Complications / Watch For |
Hemodialysis (HD) | Blood filtered via dialyzer; AV fistula/graft access | ESRD, uremia, hyperkalemia, fluid overload | Check thrill/bruit, hold antihypertensives pre-HD, monitor weight, VS, and bleeding post-HD | Hypotension, cramping, disequilibrium syndrome, access infection |
Peritoneal Dialysis (PD) | Dialysate in peritoneal cavity; exchange waste via peritoneum | CKD unable to tolerate HD, home therapy | Aseptic technique, warm dialysate, monitor inflow/outflow, weigh daily | Peritonitis (cloudy effluent), leakage, poor flow, respiratory compromise |
Continuous Renal Replacement Therapy (CRRT) | Continuous filtration in ICU; venovenous or arteriovenous | AKI with hemodynamic instability | Monitor filter, temperature, electrolyte shifts, anticoagulation | Hypothermia, filter clotting, hypotension |
Access Care
AV Fistula: Palpate thrill, auscultate bruit, no BP/IV sticks.
Central Line (Permcath): Sterile dressing, heparin locks, avoid use for other IVs.
PD Catheter: Daily care with asepsis, dry dressing, prevent contamination.
Memory Aid — D.I.A.L.Y.S.I.S.Dialysate warm • Infection prevention • Access protected • Labs trended • Yield tracked (waste removed) • Sodium balanced • Intake limited • Support coping.
🧫 5) Diagnostics & Imaging — Nursing Implications
Procedure | Nursing Considerations |
IV Pyelogram (IVP) | Check for iodine/contrast allergy, hydrate before/after, monitor for reaction |
Cystoscopy | Post-void burning expected; monitor for bleeding or infection |
Renal Biopsy | Pre: coag studies; Post: flat bedrest, monitor for flank pain, hematuria, ↓BP |
Ultrasound / CT | Noninvasive; used for stones, cysts, masses |
KUB X-ray | Detects calcifications, stones |
⚕️ 6) General & Nursing Management
Aspect | Action / Strategy | Rationale |
Fluid Regulation | Strict I&O, daily weights, adjust intake to output + insensible | Prevent overload or dehydration |
Diet Therapy | Low Na, K, Phosphate; controlled protein; high calories | Prevent electrolyte imbalance and malnutrition |
Electrolyte Monitoring | K⁺, Na⁺, Ca²⁺, Phos, Mg²⁺, Bicarb | Prevent cardiac/neuromuscular complications |
BP & CV Care | Monitor closely, adjust meds | HTN accelerates renal decline |
Skin Care | Manage pruritus, uremic frost | Comfort and infection prevention |
Psychosocial Support | Body image, treatment fatigue, lifestyle change | Chronic adjustment and adherence |
Education | Medication adherence, fluid limits, when to report (↓UO, edema, SOB) | Promotes independence & early reporting |
🧠 Quick Checks (Retrieval)
1️⃣ What GFR level defines CKD stage 5?2️⃣ Which lab confirms nephrotic syndrome?3️⃣ What is the first action after a renal biopsy if the patient reports flank pain?4️⃣ What are two key signs of peritonitis in PD?5️⃣ Which medications must be held before hemodialysis?
Answer Key (Peek):1️⃣ GFR <15 mL/min → ESRD2️⃣ Proteinuria >3.5 g/day3️⃣ Lay flat, check VS, notify provider (possible bleed)4️⃣ Cloudy effluent & abdominal pain5️⃣ Antihypertensives, antibiotics, water-soluble vitamins
🧩 NGN-Style Mini-Item
Scenario:A patient with CKD on PD reports abdominal pain, fever, and cloudy dialysate effluent. VS: BP 100/60, HR 110, T 38.9°C.
Select all priority actions:☐ Notify provider immediately☐ Send effluent for culture☐ Instill antibiotic dialysate as prescribed☐ Flush catheter with sterile saline☐ Continue current PD cycle
✅ Correct: Notify HCP • Send culture • Administer intraperitoneal antibiotics🧭 Why: These findings = peritonitis. Continuing PD risks worsening infection.
✨ Closing Practice Pearls
• “Protect the kidneys, protect the patient.”• Treat every nephrotoxic exposure as reversible harm until proven otherwise.• Dialysis is a therapy, not a cure — maintain holistic care.• Renal failure affects every organ: think multisystem.• Early recognition of subtle changes (↓UO, ↑BUN/Cr trend) saves nephrons — and lives.

Comments